Wearable Weight Loss Patches

SanPlena's 'EOPatch' Helps with Weight Loss Over Time

'SanPlena' has launched the 'EOPatch' wearable drug delivery system that aids with weight loss. SanPlena is a joint company comprised of 'EOFlow,' the drug delivery solutions company, and 'Zihipp,' the weight loss therapy company. The EOPatch is a wearable drug delivery platform that is incredibly compact. SanPlena stated that its EOPatch should be applied twice a week, which is less frequent than drugs that require daily injections.

This reduced frequency helps with managing side effects, especially when combined with the slow-release system of a patch. SanPlena claims the EOPatch delivers results of up to 10% to 15% weight loss in less than three months. The unintrusive, undemanding nature of an applied patch should help patients meet their weight loss goals, especially when combined with other health-focused practices, such as exercise and meal planning.

Image Credit: Shutterstock

Wearable Drug Delivery Systems
The EOPatch provides an opportunity to improve existing wearable drug delivery systems for other medical applications.
Compact Weight Loss Solutions
The EOPatch presents an opportunity for the development of more compact weight loss solutions, with potential for integration with exercise and meal planning technologies.
Reduced Frequency Medication Administration
The EOPatch is an example of a medication delivery system that could address issues related to reduced frequency administration, reducing side effects while improving efficacy.

Who This Affects Most

Pharmaceuticals
The EOPatch represents an opportunity for pharmaceutical companies to innovate drug delivery systems, improving their effectiveness and user-friendliness.
Fitness and Wellness
The EOPatch can be part of a complete weight loss program for fitness and wellness companies, offering an additional tool for customers seeking weight loss solutions.
Medical Technology
The EOPatch offers an opportunity to develop new medical technologies that improve quality of life by reducing medication side effects and increasing efficacy.
SCORE
3.4 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America, Europe
GENERATION
  • Gen Alpha
  • Gen Z (primary audience)
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 52%
Activity 38%
Freshness 12%